适合治疗药物监测抗精神病药物的微型采样技术
Lisanne M Geers, Anton J M Loonen1, Daniël J Touw
1University of Groningen, Groningen Research Institute of Pharmacy, Pharmacotherapy, -Epidemiology & -Economics.
Journal of clinical psychopharmacology
|April 19, 2024
概括
微量采样技术为抗精神病药物的治疗药物监测 (TDM) 提供了一种最小侵入性的替代方案. 虽然克洛扎宾具有前景,但其他抗精神病药物需要进一步验证.
科学领域:
- 药理学 药理学是指药理学的学科.
- 分析化学 分析化学
- 临床诊断 临床诊断 临床诊断
背景情况:
- 对抗精神病药物的治疗药物监测 (TDM) 对于剂量调整和合规性检查至关重要.
- 传统的TDM涉及侵入性静脉血液采样,需要诊所访问和训练有素的人员.
- 分析灵敏度的进步激发了对最小侵入性的微量采样技术的兴趣.
研究的目的:
- 审查和评估抗精神病TDM微抽样技术的现状.
- 评估这些微采样方法的临床验证和实际应用.
主要方法:
- 在PubMed和Embase数据库的系统文献搜索.
- 血液,血清或血中抗精神病药物的可用微量采样技术的概述.
- 对常规TDM识别的微量采样技术的验证状态的评估.
主要成果:
- 有几种微采样技术,包括干血斑点和体积吸收微采样.
- 十八项研究报告了抗精神病药物微抽样的化学,分析和临床验证.
- 大多数研究都存在局限性,阻碍了各种抗精神病药物的广泛采用.
结论:
- 对于克洛扎患者,建议对TDM进行微样本检测.
- 微采样代表了对其他抗精神病药物的TDM有前途的未来发展.
相关概念视频
Drug Therapy
43
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
43
Drug Concentrations: Measurements
367
Drug concentration is the quantity of a drug present in a biological sample. Measuring drug amounts in biological samples allows the clinician to understand how a drug is absorbed, distributed, metabolized, and excreted. Samples can be obtained through invasive or non-invasive methods. Invasive techniques involve surgical or parenteral interventions to gather blood, cerebrospinal fluid, or tissue biopsy. Conversely, non-invasive approaches provide samples like urine, feces, and saliva.
Plasma...
Plasma...
367
Psychosis: Goals of Pharmacotherapy
124
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
124
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
62
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
62


